Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.

[1]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[2]  R. Sharp,et al.  Genetics patients' perspectives on clinical genomic testing. , 2013, Personalized medicine.

[3]  E. Cuppen,et al.  Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  David L Veenstra,et al.  The economics of genomic medicine: insights from the IOM Roundtable on Translating Genomic-Based Research for Health. , 2013, JAMA.

[5]  J. Millán,et al.  Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process , 2013, European Journal of Human Genetics.

[6]  Dan M. Roden,et al.  Implementing genomic medicine in the clinic: the future is here , 2013, Genetics in Medicine.

[7]  L. Fleck.  Pharmacogenomics and personalized medicine: wicked problems, ragged edges and ethical precipices. , 2012, New biotechnology.

[8]  B. Knoppers,et al.  Personalized medicine and access to health care: potential for inequitable access? , 2012, European Journal of Human Genetics.

[9]  E. Juengst,et al.  After the revolution? Ethical and social challenges in 'personalized genomic medicine' , 2012, Personalized medicine.

[10]  A. Thorogood,et al.  Whole‐genome sequencing and the physician , 2012, Clinical genetics.

[11]  W. Gradishar,et al.  Barriers to the use of personalized medicine in breast cancer. , 2012, Journal of oncology practice.

[12]  Y. Bombard,et al.  Beyond the patient: The broader impact of genetic discrimination among individuals at risk of Huntington disease , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[13]  Byron C. Wallace,et al.  Update on Horizon Scans of Genetic Tests Currently Available for Clinical Use in Cancers , 2011 .

[14]  R. Sharp.  Downsizing genomic medicine: Approaching the ethical complexity of whole-genome sequencing by starting small , 2011, Genetics in Medicine.

[15]  R. Schilsky.  Personalized medicine in oncology: the future is now , 2010, Nature Reviews Drug Discovery.

[16]  S. Kamel‐Reid,et al.  Postal survey of physicians and laboratories: Practices and perceptions of molecular oncology testing , 2009, BMC health services research.

[17]  S. Merriam.  Qualitative Research: A Guide to Design and Implementation , 2009 .

[18]  R. Green,et al.  Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease , 2008, Alzheimer's & Dementia.

[19]  K. Offit,et al.  Ethical and legal implications of cancer genetic testing: do physicians have a duty to warn patients' relatives about possible genetic risks? , 2008, Journal of oncology practice.

[20]  R. Green,et al.  Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk. , 2006, Patient education and counseling.

[21]  E. Clayton.  Ethical, legal, and social implications of genomic medicine. , 2003, The New England journal of medicine.

[22]  Eleanor McLellan,et al.  Beyond the Qualitative Interview: Data Preparation and Transcription , 2003 .

[23]  G. Ginsburg,et al.  The path to personalized medicine. , 2002, Current opinion in chemical biology.

[24]  M R Anderlik,et al.  Privacy and confidentiality of genetic information: what rules for the new science? , 2001, Annual review of genomics and human genetics.

[25]  V. Braun,et al.  Please Scroll down for Article Qualitative Research in Psychology Using Thematic Analysis in Psychology , 2022 .